Brigit A. de Jong

Citrulline is an essential constituent of antigenic determinants recognized by rheumatoid arthritis-specific autoantibodies.

Gerard A. Schellekens, Brigit A. de Jong, F.H.J. van den Hoogen et al. · Journal of Clinical Investigation · 1998 · 1.4K citations · Full text

Immunology, Pathology, Immunotherapy +22

Autoantibodies to cyclic citrullinated peptides predict progression to rheumatoid arthritis in patients with undifferentiated arthritis: A prospective cohort study

F. van Gaalen, Suzanne P. Linn-Rasker, W J van Venrooij et al. · Arthritis & Rheumatism · 2004 · 636 citations · Full text

T helper type 1 and 17 cells determine efficacy of interferon-β in multiple sclerosis and experimental encephalomyelitis

Robert C. Axtell, Brigit A. de Jong, Katia Boniface et al. · Nature Medicine · 2010 · 530 citations · Full text

Cells Determine Efficacy, Autoimmune Disease, Adaptive Immune System +13

The use of PROMs and shared decision‐making in medical encounters with patients: An opportunity to deliver value‐based health care to patients

Olga C. Damman, Anant Jani, Brigit A. de Jong et al. · Journal of Evaluation in Clinical Practice · 2019 · 166 citations · Full text

Mapping of B cell epitopes on small nuclear ribonucleoproteins that react with human autoantibodies as well as with experimentally-induced mouse monoclonal antibodies.

W J Habets, M H Hoet, Brigit A. de Jong et al. · The Journal of Immunology · 1989 · 161 citations